Edition:
United Kingdom

Ypsomed Holding AG (YPSN.S)

YPSN.S on Swiss Exchange

176.90CHF
23 Jan 2018
Change (% chg)

CHF2.60 (+1.49%)
Prev Close
CHF174.30
Open
CHF176.00
Day's High
CHF177.20
Day's Low
CHF173.60
Volume
22,659
Avg. Vol
20,827
52-wk High
CHF228.70
52-wk Low
CHF132.50

Chart for

About

Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as... (more)

Overall

Beta: 0.44
Market Cap(Mil.): CHF2,027.75
Shares Outstanding(Mil.): 12.65
Dividend: 1.30
Yield (%): 0.81

Financials

  Industry Sector
P/E (TTM): -- 32.27 16.62
EPS (TTM): -- -- --
ROI: -- 13.90 10.61
ROE: -- 16.71 14.21

BRIEF-Ypsomed increases its forecast to an operating result of CHF 60 mln

* SAYS FIRST SIX MONTHS OF 2017/18, A CONSOLIDATED TOTAL TURNOVER OF CHF 213.4 MILLION. THE GROWTH CORRESPONDS TO AN INCREASE IN TURNOVER OF 15.1 PCT (PREVIOUS YEAR: CHF 185.4 MILLION)

09 Nov 2017

BRIEF-Ypsomed and US Bigfoot Biomedical company announce partnership

* ‍YPSOMED AND US BIGFOOT BIOMEDICAL COMPANY TODAY ANNOUNCED THEIR AGREEMENT FOR A PARTNERSHIP​

24 Oct 2017

BRIEF-Ypsomed Holding sets up three new subsidiaries

* YPSOMED HAS SET UP THREE FURTHER SUBSIDIARIES DURING THE PAST WEEKS, IN BELGIUM, SPAIN AND POLAND Source text: https://bit.ly/2xsYslh Further company coverage: (Gdynia Newsroom)

10 Oct 2017

Earnings vs. Estimates